Franklin Resources

Phase A — Understand the business

Lens 1 · Company Overview

Franklin Resources, Inc. ("Franklin," NYSE: BEN, S&P 500) is a holding company operating under the Franklin Templeton brand and ~20 sub-brands. It reports one operating segment: investment management and related services. It is "a global investment management organization with over $1.6 trillion in AUM as of September 30, 2025".

How it makes money. Three fee lines (fiscal-Q2-2026 quarter, ended 2026-03-31):

• Investment management fees $1,819.3M (~79% of revenue) — the core; a fee on AUM that scales with the level and mix of assets.
• Sales and distribution fees $396.6M (~17%) — largely a pass-through tied to fund sales.
• Shareholder servicing fees $69.0M + Other $10.0M.
• Total operating revenues $2,294.9M for the quarter (vs $2,111.4M a year prior, +8.7% YoY).

The 10-K is explicit on the operating reality: "our investment management fees, which represent a majority of our revenues, depend to a large extent on the level and relative mix of our AUM and the types of services provided, which are subject to change". Translation: revenue is a leveraged bet on (a) market levels, (b) net flows, and (c) fee-rate mix — and the mix has been migrating to lower-fee products (the WAM impairment below proves it).

Customers / channels. Retail, institutional, high-net-worth — individuals, sovereign wealth funds, DB/DC plans, endowments, healthcare systems, insurers — via mutual funds, closed-end funds, CITs, interval funds, private funds, SMAs, and ETFs. The customers.csv is empty; asset managers don't disclose named-client concentration, so this lens stays at the channel level by nature.

Competitors. The scaled active-and-multi-boutique cohort: Invesco (IVZ), T. Rowe Price (TROW), Janus Henderson (JHG), Affiliated Managers Group (AMG), plus the passive gorillas that structurally compress the whole industry's fee rate (BlackRock, Vanguard, State Street).

Lens 2 · Supply Chain

An asset manager's "supply chain" is the money-and-distribution pipeline, not physical inputs. Named stakeholders along the chain:

• Upstream "input" = AUM (client capital) + investment talent. Capital arrives through three doors: (1) wirehouse / broker-dealer / RIA platforms (Morgan Stanley, Merrill, LPL, Schwab/TDA) that intermediate retail; (2) institutional consultants & direct mandates (Mercer, Callan, sovereign funds); (3) the on-chain rail (BENJI app + crypto wallets via the Ondo Global Markets partnership) — a genuinely new acquisition channel. The "raw material" of talent is organized into ~20 specialist investment managers (SIMs): Western Asset, Brandywine Global, ClearBridge, Clarion Partners, Benefit Street Partners, Lexington Partners, Royce, Templeton, Putnam, K2, Martin Currie, etc..
• The company = the manufacturing/packaging layer: it wraps talent into products (funds/SMAs/ETFs/tokenized funds) and runs distribution, compliance, and the transfer-agency rails. The Benji platform is its own proprietary infrastructure — "a digital asset transfer agent, management system for digital assets, and digital wallet infrastructure".
• Downstream = the end investor, plus the on-chain ecosystem as a distribution multiplier: BENJI runs across eight public blockchains — Stellar, Polygon, Arbitrum, Aptos, Avalanche, Base, Solana, Ethereum.

Chokepoints / single-source dependencies.

1. Distribution gatekeepers. The wirehouse platforms can pull a product from the shelf; this is the asset manager's classic dependency (high bargaining power sits with the distributor).
2. Key-person risk in the SIMs — the entire WAM crisis (Lens 9/10) is a single-co-CIO chokepoint that detonated.
3. On-chain rail = third-party L1/L2 reliability + custody/oracle dependencies for the tokenized funds (small today, but a real new dependency class).

Lens 3 · Competitive Advantages (moats)

What's genuinely moaty:

• Scale + brand + 70-year distribution. $1.68T AUM and a globally-licensed retail brand are real switching-cost/scale advantages — sticky DC/retail money doesn't move on a dime.
• Alternatives breadth. $283B in alternatives AUM with $14.3B of fundraising in a single quarter is the durable growth leg — private credit (Benefit Street), secondaries (Lexington), real estate (Clarion) are high-fee, long-lock capital that passive cannot replicate. This is the strongest part of the moat.
• The tokenization first-mover edge. Franklin OnChain (FOBXX) is "the first and only U.S.-registered mutual fund to leverage a public blockchain as the system of record". Five-year head start, 8-chain reach, an actual app. In a world where RWA tokenization is the consensus next rail, being early with regulatory cover is a narrow-but-real moat.

Where the moat is weak (and this is the central problem):

• The core active product has a negative moat vs passive. The whole industry is in secular fee compression; BEN's adjusted operating margin fell from 29.9% (FY23) → 26.1% (FY24) → 24.5% (FY25). That is the moat eroding in real time.
• Bargaining power is shifting against it — distributors hold the shelf, clients can index for ~3bps, and the WAM intangible impairment is the company admitting its own contracts are worth less.

Lens 4 · Segments

BEN reports one operating segment, so the meaningful disaggregation is by asset class and by flow, both in the MD&A.

Average AUM by asset class (fiscal years, $B):

The story the table tells: fixed income (where WAM lives) is the shrinking, problem class, while equity, alternatives and multi-asset carry the firm. Mix shift toward equity/alts is good for AUM but the lower-fee migration is hurting the realized fee rate.

Ending AUM bridge, fiscal-Q2-2026 quarter (ended 2026-03-31), by class ($B):

Read it cold: the firm's first positive long-term net flow quarter in a while (+$16.9B) is carried entirely by alternatives (+$12.4B) and multi-asset (+$9.5B) — equity and fixed income are still leaking. The franchise is rotating from a decaying core to a growing periphery, but the core is not yet stabilized.

---

Phase B — Measure performance

Lens 5 · Earnings Result (latest print — fiscal Q2 2026, ended 2026-03-31)

• Total AUM $1,682.1B, down only $1.9B in the quarter (market drawdown of $30.2B nearly offset by +$28.3B total net flows). AUM is up ~9% YoY ($1,540.6B prior year).
• Operating revenues $2,294.9M, +8.7% YoY ($2,111.4M).
• Net income $268.2M, diluted EPS $0.49 — vs $151.4M / $0.26 a year ago (+77%) and vs $255.5M / $0.46 the prior quarter. H1 FY26 net income $523.7M, EPS $0.95.
• Adjusted diluted EPS $0.71 vs $0.47 a year ago, $0.70 prior quarter. (The GAAP-vs-adjusted gap is mostly intangible amortization from Legg Mason/Lexington — $50.6M in the quarter.)
• Standout positives: ETF AUM hit a record $61.6B, +67% YoY, with +$4.5B net inflows — 18th consecutive quarter of positive ETF flows. Alternatives $283B with $14.3B of fundraising in the quarter.
• The blemish: WAM still bled $4.1B of long-term net outflows — but that is down enormously from the $37B/quarter WAM was losing in late 2024. The hemorrhage is slowing to a trickle.
• Market reaction / what's priced in: stock ~$33, recovered from the ~$19.78 trough on the Aug-2024 Leech news. The recovery says the market has re-rated off the worst case but, at ~14x adjusted EPS, has not paid up for a growth re-acceleration.

Flag vs the company's own history: FY2025 GAAP operating income was $604.1M (6.9% margin), distorted downward by a $200M WAM intangible impairment and elevated amortization; FY2023 was $1,102.3M (14.0%). So GAAP earnings power is artificially suppressed right now — the adjusted line ($1,640.2M adj. operating income FY25) is the cleaner read, and even that is down 4% YoY. Earnings are stabilizing in FY26 as the impairment laps and flows turn.

Lens 6 · Earnings Calls (sentiment trend)

No transcripts on disk (transcripts/ empty). From the public record:

• Late 2024 calls (post-Leech): defensive, damage-control tone — quantifying WAM outflows, reassuring on liquidity, no guidance on when flows stabilize.
• Q2 FY26 call (Apr 2026): materially more confident — management leaned into ETF records (18 straight quarters), alternatives fundraising, BENJI/tokenization milestones, and AI, and framed WAM as a contained, healing problem rather than an open wound. CEO Jenny Johnson's external messaging is now overtly "AI, blockchain, next generation of finance".
• What they stopped saying: the existential framing around WAM. What they started saying: tokenization as a growth platform, not a science project.

Sentiment trajectory: trough (late-2024) → recovery (2025) → cautious offense (2026). The tone shift is real and corroborated by the flow turn.

Lens 7 · Comps

Peer multiples are (mixed sources/dates — treat as directional, not precise). BEN's own implied multiples are off the web price and consensus EPS.

The comp verdict that matters: on forward adjusted P/E (~14x), BEN trades at a premium to TROW/IVZ/JHG/AMG (~8–12x) despite having the worst organic flow profile of the group. The premium is not earned by growth — it is paid for the ~4% dividend and the embedded tokenization optionality. A value investor screening AMs on EV/EBITDA would pick TROW long before BEN. (5-yr avg ROE column omitted — not cleanly sourceable across the cohort without fabricating; n/a.)

Lens 8 · Stock-Price Catalysts (last ~5y, >5% moves)

Mostly ``:

• Aug 21, 2024 — −12% to $19.78, largest single-day drop since Oct 2020, on the SEC/DOJ Western Asset / Ken Leech "cherry-picking" investigation disclosure. This is the defining catalyst of the stock's last two years.
• Nov 4, 2024 — sharp drop on WAMCO $53B+ cumulative outflows + CFTC probe headline; Q4-FY24 long-term net outflows were $31.3B, +354% YoY, $37B from WAM alone.
• 2020 — Legg Mason deal (Feb announcement) re-rated the franchise as a $1.5T+ scaled manager.
• 2024–2026 — episodic crypto/tokenization pops on spot-Bitcoin-ETF (EZBC) launch, BENJI multi-chain expansions, and crypto-ETF filings — sentiment beats, not yet earnings beats.
• June 2026 — Leech guilty plea / $100M SEC settlement — a de-risking catalyst (overhang removed) more than a price spike.

Pattern: the market reacts to BEN overwhelmingly on (a) net flows and (b) franchise-integrity/regulatory risk — not on macro beta or on the crypto narrative (which moves it at the margin). The dominant variable is "is the active franchise leaking and is it clean?"

---

Phase C — Judge people & books

Lens 9 · Management

• CEO: Jenny Johnson (age 61), CEO since Feb 2020; joined 1988; ran every major division before the top job. Third-generation family leader.
• Executive Chairman: Gregory E. Johnson (age 64), her brother. The founding Johnson family controls a large equity stake — very high insider ownership and skin in the game (the company is effectively founder/family-controlled).
• Co-President & CFO/COO: Matthew Nicholls (age 53), CFO since 2019, COO since 2022, elevated to Co-President Oct 2025.

Track record (quantified). Johnson's signature move is the $4.5B Legg Mason acquisition (2020) that ~doubled the firm and pushed it past $1T, adding ~$800B AUM; plus Lexington Partners (secondaries) and Putnam — a deliberate, large-scale push into alternatives and scale. She is also the industry's most public tokenization/blockchain champion — 2026 CNBC Changemaker, overtly betting the franchise on on-chain + AI.

Capital allocation. Disciplined shareholder return: $1.28/share dividend FY25 (raised from $1.24), 10.7M shares repurchased for $240.3M FY25 (12.0M / $274.4M FY24), with a 27.2M-share authorization outstanding. Balance sheet conservative: $3.05B cash, ~$2.2B senior notes (Franklin $1.2B at 1.6–2.95%, Legg Mason $1.0B at 4.75–5.625%), $400M note repaid Mar 2025. Net cash-ish, comfortable dividend coverage.

Red flags on management. (1) The WAM blowup happened on her watch — a co-CIO ran a $600M cherry-picking fraud inside a subsidiary she owns; that is a culture/oversight indictment even though the individual, not the firm, was charged. (2) Family control cuts both ways — long-termism, but weaker external accountability and entrenchment risk. (3) The acquisition strategy has been value-accretive in scale but margin-dilutive (24.5% adj margin vs 29.9% pre-deals) and saddled the firm with the intangible-amortization drag that suppresses GAAP EPS.

Archetype: founder/family steward executing a defensive-diversification + new-rail strategy. Patient, well-capitalized, but managing decline in the core more than driving growth.

Lens 10 · Forensic Red Flags

Grounded in the filings; every figure labeled.

Accounting risk map:

• Intangibles / goodwill — the live issue. A $200.0M impairment was taken in FY2025 on the indefinite-lived intangible tied to Western Asset management contracts, cutting its carrying value to $450.0M, "primarily due to a decline in expected future growth rates and profit margins... based on a shift to lower fee products". AUM growth assumptions used were a thin 2.5%–3.1% — i.e. management itself models the WAM book as barely growing. Watch for a further impairment if WAM keeps shrinking; the remaining $450M is exposed.
• Non-GAAP flattering. Adjusted operating income ($1,640.2M) is 2.7x GAAP operating income ($604.1M) in FY25. The bridge is legitimate (intangible amortization + the impairment + acquisition items), but it means headline "adjusted" earnings systematically run far above GAAP — always read both. The consensus "EPS $2.39 FY26 / $2.73 FY27" figures are adjusted; the GAAP run-rate is roughly half (H1 GAAP EPS $0.95) — the most important provenance conflict in this dossier, flagged explicitly.
• Compensation as % of revenue. Comp & benefits $964.7M on $2,294.9M revenue (~42%) in fiscal Q2 — high but normal for the labor-intensive AM model; not a flag, but the operating-leverage lever.
• Cash vs earnings: liquid assets $5.65B, stable; no obvious receivables/inventory game (an AM has minimal working capital).

Regulatory findings (required sub-section):

• SEC EDGAR EFTS: Zero Litigation Releases and zero AAERs naming "Franklin Resources" in the 2021–2026 window. (Note: the WAM enforcement action ran against the subsidiary/individual, not the BEN parent name, so it doesn't surface in the parent-name EFTS sweep — see below.)
• The Western Asset / Ken Leech matter (material — from filings + web): An internal investigation into trade allocations of treasury derivatives in select WAM accounts triggered parallel SEC + DOJ investigations and a CFTC inquiry. Resolution as of June 2026: the CFTC closed its investigation; the DOJ agreed to resolve without filing criminal charges against WAM; former co-CIO Ken Leech pleaded guilty on 2026-06-12 to obstruction (remaining fraud charges dropped; sentencing 2026-09-21); and Western Asset agreed to a $100M civil penalty to the SEC. The alleged scheme: >$600M of favorable bond trades steered to preferred portfolios, Jan-2021→Oct-2023.
• Securities-fraud class-action exposure: multiple plaintiff firms (Kaplan Fox, Bronstein Gewirtz, BFA) opened investor investigations into BEN itself in 2024 alleging the company misled investors on the WAM situation — a civil overhang that typically follows this kind of event.

Net forensic read: The accounting is clean in the boring sense (no rev-rec games, simple balance sheet) but the WAM intangible is a slow-leak impairment risk, and the GAAP/adjusted gap is large enough to mislead a careless reader. The criminal/regulatory tail is now substantially resolved and quantified — the worst case (parent indictment / WAM franchise destruction) is off the table as of June 2026. Residual: the $100M penalty (paid), Leech sentencing, and civil class-action drift.

---

Phase D — Project & stress-test

Lens 11 · Forward Projection

Build from actuals. H1 FY26 (Oct 2025–Mar 2026) adjusted EPS is ~$1.41 ($0.70 + $0.71); GAAP EPS H1 $0.95.

Drivers: AUM ~$1.68T and rising with markets; ETF (+67% YoY) and alternatives (+$14.3B/qtr fundraising) growing; equity/fixed-income core still net-negative but decelerating outflows; fee-rate mix drifting lower; intangible amortization rolling off over time; ~520M shares with modest buyback shrinkage; ~$2.2B fixed-rate debt (cheap).

Adjusted diluted EPS:

No forecast.ts create in --watchlist mode (per SKILL). If promoted, the loggable base call would be: "BEN FY26 adjusted diluted EPS ≥ $2.80, p≈0.55, resolves 2026-09-30."

Lens 12 · Bull vs Bear

Bull case. BEN is a deep-value, high-yield turnaround with a free call option on the on-chain future. The existential WAM overhang is resolved (June 2026), flows just turned positive (+$16.9B) for the first time in years, ETF AUM is compounding at +67% and alternatives are raising $14B+ a quarter. You collect a ~4% dividend backed by a conservative balance sheet while you wait, and you get the industry's leading tokenization platform (BENJI ~$2.5B, co-leader with BlackRock's BUIDL) as a kicker in a market McKinsey sizes at $2T by 2030. If active fixed income stabilizes and the market re-rates BEN toward peers on growth rather than decay, multiple + EPS both expand.

Bear case (the permanent-impairment risks).

1. Secular fee/flow decay is structural, not cyclical. Adjusted margin 29.9%→24.5% in two years; the core active product is being indexed away. Alternatives/ETF growth has so far only offset core leakage, not driven net growth — total long-term flows have been negative for years (FY25 −$97.4B).
2. WAM franchise value keeps melting. $141.9B WAM outflow in FY25, $200M impairment, $450M carrying value still exposed; the fixed-income brand may be permanently damaged post-scandal.
3. Tokenization is a rounding error today. BENJI ~$2.5B is ~0.15% of $1.68T AUM — even a 10x to $25B is ~1.5% of AUM and, at money-market-fund fee rates, a trivial revenue contributor. The crypto narrative is real but immaterial to near-term earnings.

Pre-mortem (18 months out, thesis broke): Markets corrected, equity/FI outflows re-accelerated, a second WAM impairment hit, the civil class-actions produced a settlement, and tokenization stayed sub-scale — BEN re-rated down to ~8x like its cheapest peers and the dividend looked stretched against falling GAAP earnings.

Are multiples too high? Yes, on a relative basis: ~14x forward adjusted P/E is a premium to a peer set at ~8–12x for a franchise with worse organic growth. The premium rests on yield + optionality, both of which are defensible but not growth.

Contrarian view (what the market is refusing to see): The market is still pricing BEN as a melting active manager and treating the tokenization leadership as a press-release sideshow. If on-chain distribution becomes the dominant new retail rail this decade, BEN's five-year, 8-chain, app-plus-transfer-agent head start is a genuinely scarce strategic asset that no peer (except BlackRock) has — and it's in the stock for free. The bull's real bet is distribution-rail optionality, not fund AUM.

Lens 13 · Devil's Advocate (short-seller)

Dismantling the bull case:

• The structural break: BEN sells actively-managed alpha into a world that has decided it won't pay for it. That's not a fixable execution problem; it's the business model decaying. Every "good" data point (equity +17% avg AUM) is beta, not alpha-driven inflow — it evaporates in a drawdown.
• Revenue concentration / fragility: revenue is ~79% management fees on AUM — a leveraged bet on market levels. A 20% market drop with continued outflows takes adjusted EPS down disproportionately (operating deleverage). My bear FY28 ~$2.30 assumes a mild version of this; a real bear market is worse.
• The moat is weaker than bulls think: distribution gatekeepers and 3bps index funds hold the bargaining power; the WAM impairment is the company conceding its contracts are worth less.
• Most dangerous competitor bulls underestimate: BlackRock — not in active funds, but in tokenization. BUIDL (~$2.5B) already matches BENJI and BlackRock has infinitely more distribution, collateral-network adoption, and balance sheet. If tokenization is the prize, the incumbent gorilla eats BEN's first-mover edge.
• Worst capital-allocation history: a string of margin-dilutive acquisitions (Legg Mason/Putnam/Lexington) that grew AUM but cut the margin and loaded the GAAP P&L with amortization — buying growth that didn't show up in per-share earnings.
• Assumptions that must hold for ~$33: flows stay positive, no second WAM impairment, markets cooperative, dividend safe. Break any one and you're looking at a sub-$25 stock (the low end of the analyst range).
• The single scenario that permanently impairs: a market regime where passive + tokenized index products from BlackRock/Vanguard capture the on-chain retail rail and active outflows accelerate — BEN becomes a shrinking dividend-payer with a stranded tokenization R&D bill. Plausibility: moderate — it's the default trajectory unless active FI genuinely stabilizes.

Lens 14 · Management Questions (ordered by information value)

1. Excluding market beta, when do you expect total long-term net flows to turn sustainably positive — and what specifically drives equity and fixed-income flows back to neutral?
2. What is the realized blended fee rate trajectory, and how much of the alternatives/ETF growth is offsetting core fee compression vs adding to it?
3. Is the remaining $450M Western Asset intangible at risk of a further impairment, and what AUM-growth/margin assumptions underpin the current carrying value?
4. Post-Leech, what is the path to rebuilding the Western Asset fixed-income franchise — or is the strategy now to wind it down / re-brand?
5. Beyond the $100M SEC penalty, what is the firm's estimated exposure to the civil securities class actions, and is any of it reserved?
6. Tokenization economics: at what AUM does BENJI/Franklin OnChain become margin-accretive, and what fee rate do tokenized funds actually realize vs traditional?
7. How do you defend the tokenization lead against BlackRock BUIDL specifically, given their distribution and collateral-network advantages?
8. What is the organic (ex-acquisition, ex-market) growth rate of the firm over the last three years, and what's the target?
9. Given acquisitions have been margin-dilutive, what is the path back toward a 28–30% adjusted operating margin?
10. What is the dividend-coverage comfort level on a GAAP (not adjusted) basis if markets correct 20%?
11. How much of alternatives fundraising is genuinely incremental vs cannibalizing your own traditional products?
12. What is the capital-allocation priority for the next $2–3B — buyback, debt paydown, another acquisition, or tokenization infrastructure?
13. What key-person / oversight controls changed after WAM to ensure no other SIM can run an undetected allocation scheme?
14. How do you see AI changing your cost base and your active-management value proposition over five years?
15. Under what conditions would the family consider strategic alternatives (a larger merger) for the whole firm?

---